{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:28:02Z","timestamp":1793968082504,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI25\/02029"],"award-info":[{"award-number":["PI25\/02029"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025471","name":"Consejer\u00eda de Universidad, Investigaci\u00f3n e Innovaci\u00f3n, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2025-169910OB-I00"],"award-info":[{"award-number":["PID2025-169910OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["DGP_PIDI_2024_00138"],"award-info":[{"award-number":["DGP_PIDI_2024_00138"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119392","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:04:28Z","timestamp":1790867068000},"page":"119392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Nitrogen-functionalized 2-deoxy sp2-iminoglycolipids: Stereoselective synthesis and biological evaluation"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1394-5120","authenticated-orcid":false,"given":"Roc\u00edo","family":"Rodr\u00edguez-Mar\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-4726","authenticated-orcid":false,"given":"Francisco","family":"Mart\u00edn-Loro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2196-504X","authenticated-orcid":false,"given":"Raquel","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-4380","authenticated-orcid":false,"given":"Graciela","family":"Juez-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-5837","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"P\u00e9rez-Victoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8985-4632","authenticated-orcid":false,"given":"Adam N.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-6552","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5136-1725","authenticated-orcid":false,"given":"Ana I.","family":"Arroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8617-8234","authenticated-orcid":false,"given":"Elena M.","family":"S\u00e1nchez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7676-7721","authenticated-orcid":false,"given":"Carmen","family":"Ortiz Mellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119392_bib1","article-title":"Exploring carbohydrates for therapeutics: a review on future directions","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119392_bib2","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acs.jmedchem.0c01786","article-title":"U.S. FDA approved drugs from 2015\u2212June 2020: a perspective","volume":"64","author":"Bhutani","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/ph17030323","article-title":"Glycomimetics and glycoconjugates in drug discovery","volume":"17","author":"Xavier","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119392_bib4","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C6CC01564F","article-title":"Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases","volume":"52","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119392_bib5","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/molecules25204618","article-title":"N-Alkylated iminosugar based ligands: synthesis and inhibition of human lysosomal \u03b2-glucocerebrosidase","volume":"25","author":"Wolfsgruber","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119392_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107555","article-title":"sp2-Iminosugar azobenzene O-glycosides: Light-sensitive glycosidase inhibitors with unprecedented tunability and switching factors","volume":"150","author":"Rivero-Barbarroja","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib7","series-title":"Small Molecule Drug Discovery","first-page":"197","article-title":"sp2-Iminosugars as chemical mimics for glycodrug design","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2020"},{"key":"10.1016\/j.ejmech.2026.119392_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/pharmaceutics17060791","article-title":"Exploring a novel anti-inflammatory therapy for diabetic retinopathy based on glyco-zeolitic-imidazolate frameworks","volume":"17","author":"D\u00edaz-Paredes","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119392_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/092986708783503221","article-title":"Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives","volume":"15","author":"P\u00e9rez","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mrgentox.2016.06.007","article-title":"The antileishmanial drug miltefosine (Impavido\u00ae) causes oxidation of DNA bases, apoptosis, and necrosis in mammalian cells","volume":"806","author":"Castelo Branco","year":"2016","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2026.119392_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1573395509666131126230832","article-title":"Dysfunctional adaptive immunity during parasitic infections","volume":"9","author":"Zander","year":"2013","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.ejmech.2026.119392_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115390","article-title":"Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties","volume":"255","author":"Padilla-P\u00e9rez","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118337","article-title":"Exploring the influence of the glycone space on the therapeutic potential of sp2-iminoglycolipids","volume":"302","author":"Padilla-P\u00e9rez","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.02.078","article-title":"sp2-Iminosugar glycolipids as inhibitors of lipopolysaccharide mediated human dendritic cell activation in vitro and of acute inflammation in mice in vivo","volume":"169","author":"Schaeffer","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115973","article-title":"Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases","volume":"220","author":"Wang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119392_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","article-title":"Diversity and versatility of p38 kinase signalling in health and disease","volume":"22","author":"Canovas","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119392_bib17","article-title":"Recent insights in multi-target drugs in pharmacology and medicinal chemistry","volume":"20","author":"H\u00fcseyin Cemali","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119392_bib18","doi-asserted-by":"crossref","first-page":"9681","DOI":"10.1021\/acs.jmedchem.5c00405","article-title":"Toward dual-target glycomimetics against two bacterial lectins to fight Pseudomonas aeruginosa\u2212burkholderia cenocepacia infections: a biophysical study","volume":"68","author":"Antonini","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bioorg.2019.03.053","article-title":"Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes","volume":"87","author":"Ferhati","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib20","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1021\/acs.jmedchem.5c03703","article-title":"An orally available halothiazole glycomimetic as a cancer-targeting dual Galectin-1 and Galectin-3 inhibitor","volume":"69","author":"Zetterberg","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118453","article-title":"Selenoureido-N-alkyl-3,4,5-trihydroxypiperidines: probing their dual-target role in Gaucher disease","volume":"132","author":"Pratesi","year":"2026","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acschemneuro.4c00618","article-title":"Evidence of \u03b1-synuclein\/glucocerebrosidase dual targeting by iminosugar derivatives","volume":"16","author":"Tagliaferro","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119392_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B712690P","article-title":"Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases","volume":"6","author":"Hainrichson","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib24","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.3390\/molecules28124724","article-title":"Recent advances in chemical synthesis of amino sugars","volume":"28","author":"Yang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119392_bib25","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1021\/jm200961q","article-title":"Synthesis of antimitotic thioglycosides: in vitro and in vivo evaluation of their anticancer activity","volume":"54","author":"Garc\u00eda-\u00c1lvarez","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/md24020084","article-title":"Synthesis, biological evaluation, and computational studies of phenolic N-acetylglucosamine glycosides as \u03b1-glucosidase inhibitors","volume":"24","author":"Wang","year":"2026","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2026.119392_bib27","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1021\/acs.orglett.6b01899","article-title":"Tn Antigen mimics based on sp2-iminosugars with affinity for an anti-MUC1 antibody","volume":"18","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119392_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/cber.19290620640","article-title":"\u00dcber die Verseifung acetylierter Zucker und verwandter Substanzen","volume":"62","author":"Zempl\u00e9n","year":"1929","journal-title":"Ber. Deut. Chem. Ges."},{"key":"10.1016\/j.ejmech.2026.119392_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/ijch.202200057","article-title":"Staudinger ligation and reactions \u2013 from bioorthogonal labeling to next-generation biopharmaceuticals","volume":"63","author":"Poulou","year":"2023","journal-title":"Isr. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119392_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1122411","article-title":"Malaria and leishmaniasis: updates on co-infection","volume":"14","author":"Ornellas-Garcia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119392_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/parasitologia6020016","article-title":"Leishmaniasis vaccine development: a review of current candidates and cross-species protection potential","volume":"6","author":"Yona","year":"2026","journal-title":"Parasitologia"},{"key":"10.1016\/j.ejmech.2026.119392_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of leishmaniasis: current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.ejmech.2026.119392_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2019.03.005","article-title":"Increased ROS generation causes apoptosis-like death: mechanistic insights into the anti-leishmania activity of a potent ruthenium(II) complex","volume":"195","author":"Soares Costa","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119392_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cells14050376","article-title":"Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies","volume":"14","author":"Seo","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119392_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112379","article-title":"Which treatment modality offers the best outcomes for diabetic retinopathy? A systematic review and network meta-analysis","volume":"227","author":"Chen","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2026.119392_bib36","first-page":"35352","article-title":"Lipopolysaccharide induces inflammatory microglial activation through CD147-mediated matrix metalloproteinase expression","volume":"30","year":"2023","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.ejmech.2026.119392_bib37","article-title":"Dexamethasone in COVID-19 treatment: analyzing monotherapy and combination therapy approaches","volume":"184","author":"Mohammadmahdi Meybodi","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.ejmech.2026.119392_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1549549","article-title":"Role of inflammasomes in neuroimmune and neurodegenerative diseases: a systematic review","volume":"2018","author":"Lang","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejmech.2026.119392_bib39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119392_bib40","first-page":"3561","article-title":"Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group","volume":"41","author":"Barber","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2026.119392_bib41","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1167\/iovs.11-9241","article-title":"Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats","volume":"53","author":"Fan","year":"2012","journal-title":"Invest. Ophtalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2026.119392_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","article-title":"LPS induction of gene expression in human monocytes","volume":"13","author":"Guha","year":"2001","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.119392_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632132","article-title":"Anti-inflammatory (M2) response is induced by a sp2-iminosugar glycolipid sulfoxide in diabetic retinopathy","volume":"12","author":"Cano-Cano","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119392_bib44","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.3390\/ijms25158440","article-title":"Arylphthalide delays diabetic retinopathy via immunomodulating the early inflammatory response in an animal model of type 1 diabetes mellitus","volume":"25","author":"Mart\u00edn-Loro","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119392_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003704","article-title":"Fitness of Leishmania donovani parasites resistant to drug combinations","volume":"9","author":"Garc\u00eda-Hern\u00e1ndez","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119392_bib46","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1096\/fj.201901274RR","article-title":"Heme synthesis through the life cycle of the heme auxotrophic parasite Leishmania major","volume":"33","author":"Orrego","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2026.119392_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107092","article-title":"A yeast-based high-throughput screen identifies inhibitors of trypanosomatid HRG heme transporters with potent leishmanicidal and trypanocidal activity","volume":"63","author":"Cabello-Donayre","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.119392_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013993","article-title":"Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis","volume":"22","author":"Juez-Castillo","year":"2026","journal-title":"PLoS Pathog."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:55:18Z","timestamp":1793966118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":48,"alternative-id":["S0223523426008378"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119392","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrogen-functionalized 2-deoxy sp2-iminoglycolipids: Stereoselective synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119392"}}